Monica Shaw joined Bristol Myers Squibb Company as head of major markets in September. Based in Zurich, she is senior vice president and head of European markets, overseeing 22 countries – the company’s largest territories outside the US. But the industry is in a tricky place, contending with political pressure to cut drug prices and reduce spending more generally.
“It’s clear, particularly post-COVID, that a lot of payers have gone into cost-containment mode. I think, for the first time, we’re seeing a willingness to not have the latest innovation...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?